Senior Vice President, Portfolio Management and Corporate Operations
Mr. Knight joined Poseida in October 2018 and currently serves as Senior Vice President, Portfolio Management and Corporate Operations. In this role, he is responsible for leading Portfolio Management, Alliance Management, the Company’s Strategic Planning process, and Corporate Operations including IT, Facilities, and Environmental Health and Safety. He has over 25 years of clinical drug development experience including project/portfolio management, strategic planning, program leadership, clinical operations, data management, biostatistics, regulatory affairs, clinical outsourcing, supplier governance, clinical supply chain, procurement, and medical writing. Before joining Poseida, he was Vice President of Clinical Development Operations and Project Management at Halozyme Therapeutics. Previously, he was an Executive Director of Global Development Operations at Amgen after serving as Vice President of Clinical Operations and Project Management at Onyx Pharmaceuticals (an Amgen subsidiary). Prior to that, he held several leadership roles of increasing responsibility in clinical operations, regulatory affairs, and project management at Genentech, PRA International, and Hoechst Marion Roussel (now Sanofi). Mr. Knight earned a Master’s of Public Health (MPH) in biostatistics and epidemiology and a B.A. in psychology from the University of Oklahoma Health Sciences Center. He also earned a B.S. in nursing from the University of Kansas Medical Center.